Chief Dev. & Tech. Officer of Immunovant, Inc. (U.S.: Nasdaq:IMVT), Butchko Julia G., sells 55,318 shares worth $401,056

According to Immunovant, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Jan 11 10:58 AM, company Chief Dev. & Tech. Officer, Butchko Julia G. disclosed selling 55,318 shares at a cost of $7.25. At the time of this transaction (Jan 07), this trade was worth $401,056 in total. As of Jan 07, Butchko Julia G. now owns 289,488 shares in total worth about $2,321,693.76.

For the last few recent trades made by Immunovant, Inc. (U.S.: Nasdaq:IMVT) Chief Dev. & Tech. Officer, Butchko Julia G., we have the following information:

Posted by George Daniels on Tuesday January 11 2022, 10:38 PM EST. All trademarks acknowledged. Filed under Business, Stocks. Comments and Trackbacks closed. Follow responses: RSS 2.0